303 related articles for article (PubMed ID: 35507284)
1. Effects of Methylphenidate on the Dopamine Transporter and Beyond.
Zetterström TSC; Quansah E; Grootveld M
Curr Top Behav Neurosci; 2022; 57():127-157. PubMed ID: 35507284
[TBL] [Abstract][Full Text] [Related]
2. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
3. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
Quansah E; Zetterström TSC
Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
[TBL] [Abstract][Full Text] [Related]
4. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
6. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
Cheon KA; Ryu YH; Kim JW; Cho DY
Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
8. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
[TBL] [Abstract][Full Text] [Related]
11.
Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
[TBL] [Abstract][Full Text] [Related]
13. The dopamine transporter and attention-deficit/hyperactivity disorder.
Madras BK; Miller GM; Fischman AJ
Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014
[TBL] [Abstract][Full Text] [Related]
14. Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats.
Di Miceli M; Derf A; Gronier B
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955717
[TBL] [Abstract][Full Text] [Related]
15. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.
Somkuwar SS; Darna M; Kantak KM; Dwoskin LP
Biochem Pharmacol; 2013 Jul; 86(2):309-16. PubMed ID: 23623751
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
18. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates.
Zhang X; Talpos J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG
Neurotoxicol Teratol; 2021; 87():107017. PubMed ID: 34265415
[TBL] [Abstract][Full Text] [Related]
19. [Neuropsychopharmacological effects of methylphenidate].
Ikeda K; Takamatsu Y; Hagino Y; Sora I
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
[TBL] [Abstract][Full Text] [Related]
20. [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].
Huber M; Kirchler E; Niederhofer H; Gruber L
Fortschr Neurol Psychiatr; 2007 May; 75(5):275-84. PubMed ID: 17443438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]